Logo image of AMC.DE

ALBEMARLE CORP (AMC.DE) Stock Fundamental Analysis

FRA:AMC - Deutsche Boerse Ag - US0126531013 - Common Stock - Currency: EUR

64.85  +5.72 (+9.67%)

Fundamental Rating

3

Overall AMC gets a fundamental rating of 3 out of 10. We evaluated AMC against 67 industry peers in the Chemicals industry. While AMC seems to be doing ok healthwise, there are quite some concerns on its profitability. AMC is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

In the past year AMC has reported negative net income.
In the past year AMC had a positive cash flow from operations.
AMC had positive earnings in 4 of the past 5 years.
Each year in the past 5 years AMC had a positive operating cash flow.
AMC.DE Yearly Net Income VS EBIT VS OCF VS FCFAMC.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B -1B 2B

1.2 Ratios

Looking at the Return On Assets, with a value of -7.69%, AMC is doing worse than 76.12% of the companies in the same industry.
Looking at the Return On Equity, with a value of -13.04%, AMC is doing worse than 71.64% of the companies in the same industry.
Industry RankSector Rank
ROA -7.69%
ROE -13.04%
ROIC N/A
ROA(3y)6.03%
ROA(5y)4.56%
ROE(3y)12.4%
ROE(5y)9.64%
ROIC(3y)N/A
ROIC(5y)N/A
AMC.DE Yearly ROA, ROE, ROICAMC.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20 30

1.3 Margins

AMC's Gross Margin of 3.53% is on the low side compared to the rest of the industry. AMC is outperformed by 85.07% of its industry peers.
In the last couple of years the Gross Margin of AMC has declined.
AMC does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 3.53%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-66.02%
GM growth 5Y-49.18%
AMC.DE Yearly Profit, Operating, Gross MarginsAMC.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40

More info and screens

4

2. Health

2.1 Basic Checks

AMC does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for AMC remains at a similar level compared to 1 year ago.
Compared to 5 years ago, AMC has more shares outstanding
Compared to 1 year ago, AMC has an improved debt to assets ratio.
AMC.DE Yearly Shares OutstandingAMC.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
AMC.DE Yearly Total Debt VS Total AssetsAMC.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

2.2 Solvency

AMC has an Altman-Z score of 1.57. This is a bad value and indicates that AMC is not financially healthy and even has some risk of bankruptcy.
AMC has a Altman-Z score of 1.57. This is in the lower half of the industry: AMC underperforms 71.64% of its industry peers.
A Debt/Equity ratio of 0.31 indicates that AMC is not too dependend on debt financing.
AMC has a Debt to Equity ratio of 0.31. This is in the better half of the industry: AMC outperforms 65.67% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.31
Debt/FCF N/A
Altman-Z 1.57
ROIC/WACCN/A
WACC7.97%
AMC.DE Yearly LT Debt VS Equity VS FCFAMC.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B 8B

2.3 Liquidity

AMC has a Current Ratio of 2.11. This indicates that AMC is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 2.11, AMC is in the better half of the industry, outperforming 65.67% of the companies in the same industry.
AMC has a Quick Ratio of 1.26. This is a normal value and indicates that AMC is financially healthy and should not expect problems in meeting its short term obligations.
AMC has a Quick ratio of 1.26. This is in the better half of the industry: AMC outperforms 64.18% of its industry peers.
Industry RankSector Rank
Current Ratio 2.11
Quick Ratio 1.26
AMC.DE Yearly Current Assets VS Current LiabilitesAMC.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B 5B

More info and screens

5

3. Growth

3.1 Past

AMC shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -122.82%.
The Revenue for AMC has decreased by -39.34% in the past year. This is quite bad
The Revenue has been growing by 8.42% on average over the past years. This is quite good.
EPS 1Y (TTM)-122.82%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-169.23%
Revenue 1Y (TTM)-39.34%
Revenue growth 3Y17.35%
Revenue growth 5Y8.42%
Sales Q2Q%-20.86%

3.2 Future

The Earnings Per Share is expected to grow by 63.97% on average over the next years. This is a very strong growth
Based on estimates for the next years, AMC will show a quite strong growth in Revenue. The Revenue will grow by 13.04% on average per year.
EPS Next Y33.75%
EPS Next 2Y52.84%
EPS Next 3Y58.22%
EPS Next 5Y63.97%
Revenue Next Year-11.37%
Revenue Next 2Y-1.2%
Revenue Next 3Y4.58%
Revenue Next 5Y13.04%

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
AMC.DE Yearly Revenue VS EstimatesAMC.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 2B 4B 6B 8B 10B
AMC.DE Yearly EPS VS EstimatesAMC.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 0 10 20 30

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

AMC reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
The Price/Forward Earnings ratio is 95.49, which means the current valuation is very expensive for AMC.
AMC's Price/Forward Earnings ratio is a bit more expensive when compared to the industry. AMC is more expensive than 70.15% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 36.44. AMC is valued rather expensively when compared to this.
Industry RankSector Rank
PE N/A
Fwd PE 95.49
AMC.DE Price Earnings VS Forward Price EarningsAMC.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40 60 80

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, AMC is valued a bit more expensive than the industry average as 70.15% of the companies are valued more cheaply.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 70.08
AMC.DE Per share dataAMC.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates AMC does not grow enough to justify the current Price/Earnings ratio.
AMC's earnings are expected to grow with 58.22% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y52.84%
EPS Next 3Y58.22%

More info and screens

4

5. Dividend

5.1 Amount

AMC has a Yearly Dividend Yield of 2.18%. Purely for dividend investing, there may be better candidates out there.
AMC's Dividend Yield is a higher than the industry average which is at 2.99.
Compared to an average S&P500 Dividend Yield of 2.35, AMC has a dividend comparable with the average S&P500 company.
Industry RankSector Rank
Dividend Yield 2.18%

5.2 History

On average, the dividend of AMC grows each year by 13.04%, which is quite nice.
Dividend Growth(5Y)13.04%
Div Incr Years3
Div Non Decr Years3
AMC.DE Yearly Dividends per shareAMC.DE Yearly Dividends per shareYearly Dividends per share 2021 2022 2023 2024 2025 0.5 1 1.5

5.3 Sustainability

AMC has negative earnings and hence a negative payout ratio. The dividend may be in danger.
AMC's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP-27.05%
EPS Next 2Y52.84%
EPS Next 3Y58.22%
AMC.DE Yearly Income VS Free CF VS DividendAMC.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B -1B 2B

More info and screens

ALBEMARLE CORP

FRA:AMC (7/17/2025, 7:00:00 PM)

64.85

+5.72 (+9.67%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)04-30 2025-04-30/amc
Earnings (Next)07-30 2025-07-30/amc
Inst Owners98.3%
Inst Owner ChangeN/A
Ins Owners0.35%
Ins Owner ChangeN/A
Market Cap7.63B
Analysts69.38
Price Target69.7 (7.48%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.18%
Yearly Dividend2.27
Dividend Growth(5Y)13.04%
DP-27.05%
Div Incr Years3
Div Non Decr Years3
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)7.59%
Min EPS beat(2)-54.53%
Max EPS beat(2)69.72%
EPS beat(4)1
Avg EPS beat(4)-81.09%
Min EPS beat(4)-249.28%
Max EPS beat(4)69.72%
EPS beat(8)3
Avg EPS beat(8)-26.81%
EPS beat(12)7
Avg EPS beat(12)-12.91%
EPS beat(16)11
Avg EPS beat(16)-4.32%
Revenue beat(2)0
Avg Revenue beat(2)-8.29%
Min Revenue beat(2)-8.69%
Max Revenue beat(2)-7.88%
Revenue beat(4)1
Avg Revenue beat(4)-3.24%
Min Revenue beat(4)-8.69%
Max Revenue beat(4)5.88%
Revenue beat(8)3
Avg Revenue beat(8)-1.95%
Revenue beat(12)3
Avg Revenue beat(12)-2.81%
Revenue beat(16)5
Avg Revenue beat(16)-1.38%
PT rev (1m)-5.94%
PT rev (3m)-23.71%
EPS NQ rev (1m)-4.07%
EPS NQ rev (3m)-133.57%
EPS NY rev (1m)-5.77%
EPS NY rev (3m)-119.22%
Revenue NQ rev (1m)-0.16%
Revenue NQ rev (3m)-1.83%
Revenue NY rev (1m)-0.18%
Revenue NY rev (3m)-4.07%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 95.49
P/S 1.73
P/FCF N/A
P/OCF 7.69
P/B 0.88
P/tB 1.08
EV/EBITDA 70.08
EPS(TTM)-2.4
EYN/A
EPS(NY)0.68
Fwd EY1.05%
FCF(TTM)-1.02
FCFYN/A
OCF(TTM)8.44
OCFY13.01%
SpS37.39
BVpS73.61
TBVpS60.13
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -7.69%
ROE -13.04%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 3.53%
FCFM N/A
ROA(3y)6.03%
ROA(5y)4.56%
ROE(3y)12.4%
ROE(5y)9.64%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-66.02%
GM growth 5Y-49.18%
F-Score4
Asset Turnover0.3
Health
Industry RankSector Rank
Debt/Equity 0.31
Debt/FCF N/A
Debt/EBITDA 20.2
Cap/Depr 205.72%
Cap/Sales 25.31%
Interest Coverage N/A
Cash Conversion 742.04%
Profit Quality N/A
Current Ratio 2.11
Quick Ratio 1.26
Altman-Z 1.57
F-Score4
WACC7.97%
ROIC/WACCN/A
Cap/Depr(3y)401.9%
Cap/Depr(5y)389.55%
Cap/Sales(3y)23.64%
Cap/Sales(5y)25.35%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-122.82%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-169.23%
EPS Next Y33.75%
EPS Next 2Y52.84%
EPS Next 3Y58.22%
EPS Next 5Y63.97%
Revenue 1Y (TTM)-39.34%
Revenue growth 3Y17.35%
Revenue growth 5Y8.42%
Sales Q2Q%-20.86%
Revenue Next Year-11.37%
Revenue Next 2Y-1.2%
Revenue Next 3Y4.58%
Revenue Next 5Y13.04%
EBIT growth 1Y40.47%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year156.87%
EBIT Next 3Y44.72%
EBIT Next 5Y38.95%
FCF growth 1Y-114.29%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-52.55%
OCF growth 3Y26.81%
OCF growth 5Y-0.49%